Adare served as a trusted development and manufacturing partner from the earliest days of of clinical development for a customer's orphan disease treatment and continuing through to FDA fast-track review and commercial launch.
Along the way, Adare’s team of experts guided formulation, scale-up, analytical testing, regulatory report preparation, and ultimately commercialization for the product, resulting in a powerful and ongoing collaboration that facilitated accelerated patient access to a critical therapy.
